indazoles has been researched along with Eczema, Atopic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carnerup, MA; Dack, KN; Eirefelt, S; Henriksson, K; Johnson, PS; Ollerstam, AK; Stahlhut, M | 1 |
| Dainichi, T; Hirakawa, S; Honda, T; Kabashima, K; Kitoh, A; Miyachi, Y; Nakajima, S; Nakashima, C; Nonomura, Y; Otsuka, A; Wong, LS; Yamamoto, Y | 1 |
2 other study(ies) available for indazoles and Eczema, Atopic
| Article | Year |
|---|---|
Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
Topics: Administration, Topical; Dermatitis, Atopic; Drug Design; Drug Stability; Half-Life; Humans; Indazoles; Leukocytes, Mononuclear; Lipopolysaccharides; Psoriasis; Receptors, Glucocorticoid; Steroids; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2020 |
Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice.
Topics: Aminoquinolines; Animals; Axitinib; Dermatitis, Atopic; Disease Models, Animal; Epidermis; Humans; Imidazoles; Imiquimod; Indazoles; Mice; Pruritus; Psoriasis; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2016 |